A Clash of Old and New Scientific Concepts in Toxicity, with Important Implications for Public Health

Environmental Health Sciences, Charlottesville, Virginia 22902, USA.
Environmental Health Perspectives (Impact Factor: 7.98). 11/2009; 117(11):1652-5. DOI: 10.1289/ehp.0900887
Source: PubMed


A core assumption of current toxicologic procedures used to establish health standards for chemical exposures is that testing the safety of chemicals at high doses can be used to predict the effects of low-dose exposures, such as those common in the general population. This assumption is based on the precept that "the dose makes the poison": higher doses will cause greater effects.
We challenge the validity of assuming that high-dose testing can be used to predict low-dose effects for contaminants that behave like hormones. We review data from endocrinology and toxicology that falsify this assumption and summarize current mechanistic understanding of how low doses can lead to effects unpredictable from high-dose experiments.
Falsification of this assumption raises profound issues for regulatory toxicology. Many exposure standards are based on this assumption. Rejecting the assumption will require that these standards be reevaluated and that procedures employed to set health standards be changed. The consequences of these changes may be significant for public health because of the range of health conditions now plausibly linked to exposure to endocrine-disrupting contaminants.
We recommend that procedures to establish acceptable exposure levels for endocrine-disrupting compounds incorporate the inability for high-dose tests to predict low-dose results. Setting acceptable levels of exposure must include testing for health consequences at prevalent levels of human exposure, not extrapolations from the effects observed in high-dose experiments. Scientists trained in endocrinology must be engaged systematically in standard setting for endocrine-disrupting compounds.

Download full-text


Available from: Tom Zoeller, Nov 04, 2014
  • Source
    • "All of them are released to the environment via different sources and are presented simultaneously instead of separately . Thus, these chemicals not only have adverse effects on organisms at very low-level exposure (Myers et al., 2009), but also have the potential of additive or even synergistic effects when acting in combination (Kunz and Fent, 2006; Sun et al., 2009). Estrogenic chemicals have been the focus of many studies for a long time. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The increasing amounts of various estrogenic chemicals coexisting in the aquatic environment may pose environmental risks. While the concept of estradiol equivalent (EEQ) has been frequently applied in studying estrogenic mixtures, few experiments have been done to prove its reliability. In this study, the reliability of EEQ and the related model concentration addition (CA) was verified based on the two-hybrid recombinant yeast bioassay when all mixture components had the same mode of action and target of action. Our results showed that the measured estrogenic effects could be well predicted by CA and EEQ for all laboratory-made mixtures using two designs, despite the varying estrogenic activity, concentration levels and ratios of the test chemicals. This suggests that when an appropriate endpoint and its relevant bioassay are chosen, CA should be valid and the application of EEQ in predicting the effect of non-equi-effect mixtures is feasible.
    Full-text · Article · Nov 2014 · Environmental Toxicology and Pharmacology
  • Source
    • "Most of these applications used the threshold model which was based on the monotonic CRCs (Myers et al., 2009; Billionnet et al., 2012). However, the threshold model is unsuitable to assess the risk of chemicals with non-monotonic CRCs, where the effects of some chemicals were not simply increase or decrease over concentrations (Myers et al., 2009). For example, non-monotonic J-shaped CRCs represent hormesis, where the stimulatory effects firstly increased and then decreased over time, and even changed into inhibitory effects (Calabrese, 2008). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The threshold model based on monotonic concentration-response curves (CRCs) is unsuitable to assess the risk of chemicals with non-monotonic CRCs. The non-monotonic CRCs of mixtures may relate to the characteristics of some individual component. To reveal the cause of the mixtures resulting in the non-monotonic CRCs, we used the microplate toxicity analysis to determine the toxicity effects of six 1-alkyl-3-methyl-imidazolium ([amim]X) salts and their mixtures on Vibrio qinghaiensis sp.-Q67 (Q67). It was shown that the CRCs of six [amim]X salts are monotonic S-shaped while those of the senary mixtures designed by the uniform design ray (UD-ray) are all non-monotonic. The mixtures were further split into two ternary mixtures, one containing 1-ethyl-3-methyl-imidazolium ([emim]X) salts (noted as UTE) and the other one containing 1-butyl-3-methyl-imidazolium ([bmim]X) salts (noted as UTB). It was found that the CRCs of UTE mixtures are all non-monotonically J-shaped, while only one (UTB-R3) among UTB mixtures has a little stimulating effect and the CRCs of the other three mixtures (UTB-R1, UTB-R2 and UTB-R4) are monotonic. The CRCs of the binary mixtures designed by the direct equipartition ray design (EquRay) procedure were further examined. The CRCs of the mixtures containing [emim]Cl are non-monotonic J-shaped while those of the mixtures without [emim]Cl are still monotonic. Thus, it can conclude that it is [emim]Cl that causes the non-monotonic CRCs in [amim]X mixtures, even though the CRC of individual [emim]Cl is monotonic.
    Full-text · Article · Oct 2014 · Chemosphere
  • Source
    • "cell proliferation vs cytotoxicity), this concept is not so clear when considering in vivo toxicity studies. This uncertainty, coupled with published in vivo data in particular using bisphenol A (BPA) (Vandenberg et al., 2009; Wetherill et al., 2002), has led to the current toxicology testing paradigm being heavily challenged and suggested being inadequate to fully evaluate the toxicity profile of a given chemical (Myers et al., 2009). Specifically, the dose levels used as well as the parameters measured in standard regulatory toxicity studies are considered to be insufficient to identify low dose effects (Vandenberg et al., 2012). "
    [Show abstract] [Hide abstract]
    ABSTRACT: The dose-response characterization of endocrine mediated toxicity is an on-going debate which is controversial when exploring the nature of the dose-response curve and the effect at the low-end of the curve. To contribute to this debate we have assessed the effects of a wide range of dose levels of the antiandrogen flutamide (FLU) on 7-week male Wistar rats. FLU was administered by oral gavage at doses of 0, 0.001, 0.01, 0.1, 1 and 10mg/kg/day for 28days. To evaluate the reproducibility, the study was performed 3 times. The molecular initiating event (MIE; AR antagonism), the key events (LH increase, Leydig cell proliferation and hyperplasia increases) and associated events involved in the mode of action (MOA) of FLU induced testicular toxicity were characterized to address the dose response concordance. Results showed no effects at low doses (<0.1mg/kg/day) for the different key events studied. The histopathological changes (Leydig cell hyperplasia) observed at 1 and 10mg/kg/day were associated with an increase in steroidogenesis gene expression in the testis from 1mg/kg/day, as well as an increase in testosterone blood level at 10mg/kg/day. Each key event dose-response was in good concordance with the MOA of FLU on the testis. From the available results, only monotonic dose-response curves were observed for the MIE, the key events, associated events and in effects observed in other sex related tissues. All the results, so far, show that the reference endocrine disruptor FLU induces threshold effects in a standard 28-day toxicity study on adult male rats.
    Preview · Article · Sep 2014 · Toxicology Letters
Show more